TP53 and non-small cell lung carcinoma: Non-disruptive TP53 mutations (those preserving some functional properties of the protein) represent an independent prognostic factor of shorter OS in advanced NSCLC (13.3 versus 24.6 months; HR = 2.08; p < 0.001) [26].